Cargando…

SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study

OBJECTIVES: First, to describe SARS-CoV-2 T cell and antibody responses in a prospective cohort of healthcare workers that suffered from mild to moderate COVID-19 approximately one year ago. Second, to assess COVID-19 vaccine-induced immune responses in these prior-infected individuals. METHODS: SAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mak, Willem A., Koeleman, Johannes G.M., van der Vliet, Marijke, Keuren, Frans, Ong, David S.Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656179/ https://www.ncbi.nlm.nih.gov/pubmed/34896516 http://dx.doi.org/10.1016/j.jinf.2021.12.003

Ejemplares similares

SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19
por: Ong, David S.Y., et al.
Publicado: (2021)

Dynamics of Antibody and T Cell Immunity against SARS-CoV-2 Variants of Concern and the Impact of Booster Vaccinations in Previously Infected and Infection-Naïve Individuals
por: Faas, Michel R., et al.
Publicado: (2022)

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals
por: Mak, Willem A., et al.
Publicado: (2022)

Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method
por: Mak, Willem A., et al.
Publicado: (2022)

Rapid screening method for the detection of SARS-CoV-2 variants of concern
por: Ong, David S.Y., et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

SARS-COV-2 antibodies after booster vaccination. Identification of subgroups with poor response
por: Ayuso García, B., et al.
Publicado: (2023)

Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies
por: Rick, Anne-Marie, et al.
Publicado: (2023)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors
por: Lu, Bi-Nan, et al.
Publicado: (2022)

Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
por: Quee, F. A., et al.
Publicado: (2023)

High Levels of Anti-SARS-CoV-2 Receptor-Binding Domain (RBD) Antibodies One Year Post Booster Vaccinations among Hospital Workers in Indonesia: Was the Second Booster Needed?
por: Muslimah, Amila Hanifan, et al.
Publicado: (2023)

Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
por: Kim, Jinyong, et al.
Publicado: (2022)

Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study
por: Kawashima, Moe, et al.
Publicado: (2023)

The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
por: Tworek, Adam, et al.
Publicado: (2023)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations
por: Mulleners, Sien J., et al.
Publicado: (2023)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination
por: Buckner, Clarisa M., et al.
Publicado: (2022)

Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
por: Koeleman, Johannes G. M., et al.
Publicado: (2021)

SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
por: Wang, Qian, et al.
Publicado: (2023)

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
por: Piñana, José Luis, et al.
Publicado: (2023)

Sars-Cov-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Transplant Recipients
por: Clemenceau, Beatrice, et al.
Publicado: (2022)

COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
por: Swadźba, Jakub, et al.
Publicado: (2023)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021)

The societal value of SARS-CoV-2 booster vaccination in Indonesia
por: Johnson, Rob, et al.
Publicado: (2023)

Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
por: Quiroga, Borja, et al.
Publicado: (2022)

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
por: Lusvarghi, Sabrina, et al.
Publicado: (2021)

Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
por: Vietri, Maria Teresa, et al.
Publicado: (2022)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Studying the effects of booster shots and antibody responses to the SARS-CoV-2 vaccination over time in health personnel
por: Wu, Jingjing, et al.
Publicado: (2023)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Antibody levels following booster SARS-CoV-2 vaccination among dialysis patients initially vaccinated with adenovirus vector-based vaccine
por: Willetts, Joanna, et al.
Publicado: (2023)

Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
por: Greenberger, Lee M., et al.
Publicado: (2021)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
por: Wang, Xun, et al.
Publicado: (2022)

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
por: Moreno, Alberto, et al.
Publicado: (2023)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eetfs1ld6nnuntoblfhvgbj896